Oxalo Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1M
- Investors
-
5
Oxalo Therapeutics General Information
Description
Developer of a novel drug therapy designed to treat and prevent recurrent kidney stones. The company's therapy is derived from a gut bacterium to prevent and treat diseases such as hyperoxaluria and oxalate-based kidney stones, as well as renal diseases caused by high levels of oxalate in the body, enabling healthcare professionals to remove oxalate safely from the body of a patient and consequently prevent the recurrence of stones.
Contact Information
Website
www.oxalotherapeutics.comCorporate Office
- Polsky Exchange, 1452 East 53rd Street
- 2nd Floor
- Chicago, IL 60615
- United States
Corporate Office
- Polsky Exchange, 1452 East 53rd Street
- 2nd Floor
- Chicago, IL 60615
- United States
Oxalo Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Grant | 15-Apr-2022 | $1M | Completed | Startup | ||
| 6. Grant | 28-Jun-2019 | Completed | Startup | |||
| 5. Accelerator/Incubator | 17-Oct-2018 | Completed | Startup | |||
| 4. Grant | 19-Sep-2018 | Completed | Startup | |||
| 3. Accelerator/Incubator | 01-May-2018 | Completed | Startup | |||
| 2. Accelerator/Incubator | 06-Dec-2017 | $250K | $250K | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2017 | Completed | Startup |
Oxalo Therapeutics Signals
Oxalo Therapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| US National Science Foundation | Accelerator/Incubator | |||
| MassChallenge | Accelerator/Incubator | |||
| National Institutes of Health | Government | |||
| Polsky Center for Entrepreneurship and Innovation at the University of Chicago | Accelerator/Incubator | Minority | ||
| University of Chicago | University |
Oxalo Therapeutics FAQs
-
When was Oxalo Therapeutics founded?
Oxalo Therapeutics was founded in 2017.
-
Where is Oxalo Therapeutics headquartered?
Oxalo Therapeutics is headquartered in Chicago, IL.
-
What is the size of Oxalo Therapeutics?
Oxalo Therapeutics has 2 total employees.
-
What industry is Oxalo Therapeutics in?
Oxalo Therapeutics’s primary industry is Drug Discovery.
-
Is Oxalo Therapeutics a private or public company?
Oxalo Therapeutics is a Private company.
-
What is Oxalo Therapeutics’s current revenue?
The current revenue for Oxalo Therapeutics is .
-
How much funding has Oxalo Therapeutics raised over time?
Oxalo Therapeutics has raised $350K.
-
Who are Oxalo Therapeutics’s investors?
US National Science Foundation, MassChallenge, National Institutes of Health, Polsky Center for Entrepreneurship and Innovation at the University of Chicago, and University of Chicago have invested in Oxalo Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process